Here, ZVI@CMC was recognized as a DNMT inhibitor to re-express the silenced SOX17 in ESCC, and hence suppressing the activation of NRF2-mediated cytoprotective programs. Here, DNMT1 is linked to esophageal squamous cell carcinoma.